Stock-Based Compensation for West Pharmaceutical Services (WST)
Stock-Based Compensation for West Pharmaceutical Services (WST): headline value $29.10M · YoY +27.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingStock-Based CompensationSwitch metric
Latest period
$29.10M
YoY change
+27.3%
5Y CAGR
-6.9%
Peak year (2021)
$37.50M
Latest annual
$23.80M
Stock-Based Compensation history chart for West Pharmaceutical Services (WST) from 1989 to 2025
Stock-Based Compensation history table for West Pharmaceutical Services (WST) from 1989 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $23.80M | +27.3% | ||
| 2024 | $18.70M | -19.7% | ||
| 2023 | $23.30M | -1.7% | ||
| 2022 | $23.70M | -36.8% | ||
| 2021 | $37.50M | +10.3% | ||
| 2020 | $34.00M | +39.3% | ||
| 2019 | $24.40M | +61.6% | ||
| 2018 | $15.10M | -6.2% | ||
| 2017 | $16.10M | -17.4% | ||
| 2016 | $19.50M | -34.1% | ||
| 2015 | $29.60M | +59.1% | ||
| 2014 | $18.60M | -12.3% | ||
| 2013 | $21.20M | +36.8% | ||
| 2012 | $15.50M | +84.5% | ||
| 2011 | $8.40M | +7.7% | ||
| 2010 | $7.80M | +4.0% | ||
| 2009 | $7.50M | +17.2% | ||
| 2008 | $6.40M | — | ||
| 2007 | $0 | — | ||
| 2006 | $0 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | — |
Stock-Based Compensation values are taken from West Pharmaceutical Services's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual stock-based compensation for West Pharmaceutical Services (WST) came in at $23.80M – grew 27.3% year-over-year.
West Pharmaceutical Services stock-based compensation compound annual growth for the 2020–2025 (5 years) window is -6.9%, with a net decline across the window.
The dataset's maximum stock-based compensation sits at $37.50M (2021); the minimum reading of $0 dates to 1989.
Within Healthcare, West Pharmaceutical Services (WST) ranks 5th among 8 peers we track. The peer median for stock-based compensation is $313.00M.
West Pharmaceutical Services Stock-Based Compensation by Year
West Pharmaceutical Services Stock-Based Compensation 2025: $23.80M
West Pharmaceutical Services stock-based compensation in 2025 was $23.80M, grew 27.3% from 2024.
West Pharmaceutical Services Stock-Based Compensation 2024: $18.70M
West Pharmaceutical Services stock-based compensation in 2024 was $18.70M, declined 19.7% below 2023.
West Pharmaceutical Services Stock-Based Compensation 2023: $23.30M
West Pharmaceutical Services stock-based compensation in 2023 was $23.30M, edged down 1.7% below 2022.
West Pharmaceutical Services Stock-Based Compensation 2022: $23.70M
West Pharmaceutical Services stock-based compensation in 2022 was $23.70M, plunged 36.8% below 2021.
West Pharmaceutical Services Stock-Based Compensation 2021: $37.50M
West Pharmaceutical Services stock-based compensation in 2021 was $37.50M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — Stock-Based Compensation
Companies in the same sector as West Pharmaceutical Services, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's stock-based compensation?
Latest reported stock-based compensation for West Pharmaceutical Services (WST) is $29.10M (period ending March 31, 2026).
How has West Pharmaceutical Services stock-based compensation changed year-over-year?
West Pharmaceutical Services (WST) stock-based compensation changed +27.3% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services stock-based compensation?
West Pharmaceutical Services (WST) stock-based compensation compound annual growth rate is -6.9% over the most recent 5 years available.
When did West Pharmaceutical Services stock-based compensation hit its highest annual value?
West Pharmaceutical Services stock-based compensation reached its highest annual value of $37.50M in 2021.
What was West Pharmaceutical Services stock-based compensation in 2024?
West Pharmaceutical Services (WST) stock-based compensation in 2024 was $18.70M.
What was West Pharmaceutical Services stock-based compensation in 2025?
West Pharmaceutical Services (WST) stock-based compensation in 2025 was $23.80M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.